Picture of Idox logo

IDOX Idox News Story

0.000.00%
gb flag iconLast trade - 00:00
TechnologyConservativeSmall CapHigh Flyer

RCS - IDOX PLC - Progressive publishes new research




 



RNS Number : 1688K
IDOX PLC
20 April 2020
 

A new dawn

Idox presents an unusual investment opportunity - a business deeply embedded in customer markets for many years (even decades) but one also ready to benefit from a major revitalisation, to move with its customers to more modern and higher margin SaaS-based delivery and relatively resilient to Covid-19 pressures.  We provide an overview of the group, and look forward to 2020 delivering on the back of a solid 2019 result.

 

Click here for full analysis

 

Subscribe to Progressive's research, which is freely available to every type of investor, and be kept informed about our regular programme of investor engagement. 

About Progressive:

 

Progressive is an equity research and investor engagement company.  FCA authorised and regulated, the firm has a 15-strong team of highly experienced analysts.  We provide Institutional grade research and connect companies with investors across every sector of the market.

 

www.progressive-research.com

 

Broad coverage

 

Analyst calibre

 

across 12 sectors

 

 

 



 

 

 

Business Services

Oil & Gas

15
analysts

with average

20
years

Financials

Property

experience of

Healthcare

Retail


Industrials

Technology

30+


techMARK

Investment Trusts

Telecoms

industry based

Extel

Mining

Utilities

awards

StarMine

 

 

For further information please contact:

 

Emily Ritchie

+44 (0) 20 7781 5311

eritchie@progressive-research.com


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAKKKBQABKKFQB

Recent news on Idox

See all news